Advisory Commission of Childhood Vaccines; Request for Nominations for Voting Members, 33234-33235 [E7-11548]
Download as PDF
<![CDATA[
33234
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
L. 104–13), the Health Resources and
Services Administration (HRSA) will
publish periodic summaries of proposed
projects being developed for submission
to OMB under the Paperwork Reduction
Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans, call the HRSA Reports Clearance
Officer on (301) 443–1129.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
of other forms of information
technology.
Proposed Project: The Nursing
Education Loan Repayment Program
Application (OMB No. 0915–0140)—
Revision
This is a request for revision of the
Nursing Education Loan Repayment
Program (NELRP) application and
participant monitoring forms. The
NELRP was originally authorized by 42
U.S.C. 297b(h) (section 836(h) of the
Public Health Service Act) as amended
by Public Law 100–607, November 4,
1988. The NELRP is currently
authorized by 42 U.S.C. 297n (section
846 of the Public Health Service Act) as
amended by Public Law 107–205,
August 1, 2002.
Under the NELRP, registered nurses
are offered the opportunity to enter into
a contractual agreement with the
Secretary to receive loan repayment for
Responses
per
respondents
Number of
respondents
Form
Estimates of Annualized Hour Burden are as Follows for
Applicants:
NELRP Application .....................................................
Loan Verification Form ...............................................
Applicant Employment Verification Form ...................
Payment Information Form .........................................
Application Checklist ...................................................
Pre-Award Confirmation Checklist ..............................
up to 85 percent of their qualifying
educational loan balance as follows: 30
percent each year for the first 2 years
and 25 percent for the third year. In
exchange, the nurses agree to serve fulltime as a registered nurse for 2 or 3
years at a health care facility with a
critical shortage of nurses.
NELRP requires the following
information:
1. Applicants must provide
information on their nursing education,
employment, and proposed service site;
2. Applicants must provide
information on their outstanding
nursing educational loans;
3. Applicants must provide banking
information from their financial
institution; and
4. Employers must provide
information on the health care facility
and on the employment status of
applicants and participants.
Total
responses
Hours per
response
Total burden
hours
5,000
5,000
5,000
5,000
5,000
600
1
3
1
1
1
1
5,000
15,000
5,000
5,000
5,000
600
1.5
1
.5
1
.5
.25
7,500
15,000
2,500
5,000
2,500
150
Total .....................................................................
Estimates of Annualized Hour Burden are as Follows for
Participants:
Participant Semi-Annual Employment Verification
Form ........................................................................
5,000
........................
35,600
..........................
32,650
1,300
2
2,600
.5
1,300
Total .....................................................................
1,300
2
2,600
.5
1,300
Send comments to Susan G. Queen,
Ph.D., HRSA Reports Clearance Officer,
Room 10–33 Parklawn Building, 5600
Fishers Lane, Rockville, Maryland
20857. Written comments should be
received with 60 days of this notice.
Dated: June 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7–11557 Filed 6–14–07; 8:45 am]
jlentini on PROD1PC65 with NOTICES
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Commission of Childhood
Vaccines; Request for Nominations for
Voting Members
Health Resources and Services
Administration, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: The Health Resources and
Services Administration (HRSA) is
requesting nominations to fill three
vacancies on the Advisory Commission
on Childhood Vaccines (ACCV). The
ACCV was established by Title XXI of
the Public Health Service Act (the Act),
as enacted by Public Law (Pub. L.) 99–
660 and as subsequently amended, and
advises the Secretary of Health and
VerDate Aug<31>2005
19:26 Jun 14, 2007
Jkt 211001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Human Services (the Secretary) on
issues related to implementation of the
National Vaccine Injury Compensation
Program (VICP).
DATES: The agency must receive
nominations on or before July 16, 2007.
ADDRESSES: All nominations are to be
submitted to the Director, Division of
Vaccine Injury Compensation,
Healthcare Systems Bureau (HSB),
HRSA, Parklawn Building, Room 11C–
26, 5600 Fishers Lane, Rockville,
Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms.
Delia Jones, Principal Staff Liaison,
Policy Analysis Branch, Division of
Vaccine Injury Compensation, HSB,
HRSA at (301) 443–6593 or e-mail:
djones2@hrsa.gov.
SUPPLEMENTARY INFORMATION: Under the
authorities that established the ACCV,
the Federal Advisory Committee Act of
October 6, 1972 (Pub. L. 92–463) and
E:\FR\FM\15JNN1.SGM
15JNN1
jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / Notices
section 2119 of the Act, 42 U.S.C.
300aa–19, as added by Public Law 99–
660 and amended, HRSA is requesting
nominations for three voting members
of the ACCV.
The ACCV advises the Secretary on
the implementation of the VICP. The
activities of the ACCV include:
recommending changes in the Vaccine
Injury Table at its own initiative or as
the result of the filing of a petition;
advising the Secretary in implementing
section 2127 regarding the need for
childhood vaccination products that
result in fewer or no significant adverse
reactions; surveying Federal, State, and
local programs and activities related to
gathering information on injuries
associated with the administration of
childhood vaccines, including the
adverse reaction reporting requirements
of section 2125(b); advising the
Secretary on the methods of obtaining,
compiling, publishing, and using
credible data related to the frequency
and severity of adverse reactions
associated with childhood vaccines; and
recommending to the Director of the
National Vaccine Program that vaccine
safety research be conducted on various
vaccine injuries.
The ACCV consists of nine voting
members appointed by the Secretary as
follows: (1) Three health professionals,
who are not employees of the United
States Government and have expertise
in the health care of children, and the
epidemiology, etiology, and prevention
of childhood diseases, and the adverse
reactions associated with vaccines, at
least two shall be pediatricians; (2) three
members from the general public, at
least two shall be legal representatives
(parents or guardians) of children who
have suffered a vaccine-related injury or
death; and (3) three attorneys, at least
one shall be an attorney whose specialty
includes representation of persons who
have suffered a vaccine-related injury or
death, and one shall be an attorney
whose specialty includes representation
of vaccine manufacturers. In addition,
the Director of the National Institutes of
Health, the Assistant Secretary for
Health, the Director of the Centers for
Disease Control and Prevention, and the
Commissioner of the Food and Drug
Administration (or the designees of such
officials) serve as nonvoting ex officio
members.
Specifically, HRSA is requesting
nominations for three voting members
of the ACCV representing: (1) A
pediatrician who has expertise in the
health care of children, the
epidemiology, etiology, and prevention
of childhood diseases, and the adverse
reactions associated with vaccines; (2) a
member of the general public who is the
VerDate Aug<31>2005
19:26 Jun 14, 2007
Jkt 211001
legal representative of a child who has
suffered a vaccine injury or death; and
(3) an attorney whose specialty includes
representation of persons who have
suffered vaccine injuries or deaths.
Nominees will be invited to serve a 3year term beginning January 1, 2008,
and ending December 31, 2010.
Interested persons may nominate one
or more qualified persons for
membership on the ACCV. Nominations
shall state that the nominee is willing to
serve as a member of the ACCV and
appears to have no conflict of interest
that would preclude the ACCV
membership. Potential candidates will
be asked to provide detailed information
concerning consultancies, research
grants, or contracts to permit evaluation
of possible sources of conflicts of
interest. A curriculum vitae or resume
should be submitted with the
nomination.
The Department of Health and Human
Services has special interest in assuring
that women, minority groups, and the
physically disabled are adequately
represented on advisory committees;
and therefore, extends particular
encouragement to nominations for
appropriately qualified female,
minority, or disabled candidates.
Dated: June 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7–11548 Filed 6–14–07; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the thirteenth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
on Tuesday, July 10, 2007, from 8:30
a.m. to approximately 5 p.m. in Room
800 of the Hubert H. Humphrey
Building, 200 Independence Avenue,
SW., Washington, DC 20001. The
meeting will be open to the public with
attendance limited to space available.
The meeting also will be Web cast.
The meeting will focus primarily on
the issue of gene patents and licensing
practices and consist of a series of
presentations and discussions involving
international experts on how other
countries are addressing questions
related to the impact of gene patents and
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
33235
licensing practices on patient access to
genetic tests. In addition, the SACGHS
task force on oversight of genetic testing
will present a brief report on the
progress of its fact-finding and
consultative efforts with regard to the
Secretary’s charge. The Committee will
also be updated about the public
comments received in response to the
Committee’s solicitation on its draft
report on pharmacogenomics.
Time will be provided for public
comments. The Committee would
welcome hearing from anyone wishing
to provide public comment on any issue
related to genetics, health, and society.
Individuals who would like to provide
public comment should notify the
SACGHS Executive Secretary, Ms. Sarah
Carr, by telephone at 301–496–9838 or
e-mail at carrs@od.nih.gov. The
SACGHS office is located at 6705
Rockledge Drive, Suite 750, Bethesda,
MD 20892. Anyone planning to attend
the meeting who is in need of special
assistance, such as sign language
interpretation or other reasonable
accommodations, is also asked to
contact the Executive Secretary.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the broad range of
human health and societal issues raised
by the development and use of genetic
and genomic technologies and, as
warranted, to provide advice on these
issues. The draft meeting agenda and
other information about SACGHS,
including information about access to
the Web cast, will be available at the
following Web site: https://
www4.od.nih.gov/oba/sacghs.htm.
Dated: June 7, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–2964 Filed 6–14–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Alternative Medicine, Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
E:\FR\FM\15JNN1.SGM
15JNN1
]]>Agencies
[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Notices]
[Pages 33234-33235]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11548]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission of Childhood Vaccines; Request for
Nominations for Voting Members
AGENCY: Health Resources and Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Health Resources and Services Administration (HRSA) is
requesting nominations to fill three vacancies on the Advisory
Commission on Childhood Vaccines (ACCV). The ACCV was established by
Title XXI of the Public Health Service Act (the Act), as enacted by
Public Law (Pub. L.) 99-660 and as subsequently amended, and advises
the Secretary of Health and Human Services (the Secretary) on issues
related to implementation of the National Vaccine Injury Compensation
Program (VICP).
DATES: The agency must receive nominations on or before July 16, 2007.
ADDRESSES: All nominations are to be submitted to the Director,
Division of Vaccine Injury Compensation, Healthcare Systems Bureau
(HSB), HRSA, Parklawn Building, Room 11C-26, 5600 Fishers Lane,
Rockville, Maryland 20857.
FOR FURTHER INFORMATION CONTACT: Ms. Delia Jones, Principal Staff
Liaison, Policy Analysis Branch, Division of Vaccine Injury
Compensation, HSB, HRSA at (301) 443-6593 or e-mail: djones2@hrsa.gov.
SUPPLEMENTARY INFORMATION: Under the authorities that established the
ACCV, the Federal Advisory Committee Act of October 6, 1972 (Pub. L.
92-463) and
[[Page 33235]]
section 2119 of the Act, 42 U.S.C. 300aa-19, as added by Public Law 99-
660 and amended, HRSA is requesting nominations for three voting
members of the ACCV.
The ACCV advises the Secretary on the implementation of the VICP.
The activities of the ACCV include: recommending changes in the Vaccine
Injury Table at its own initiative or as the result of the filing of a
petition; advising the Secretary in implementing section 2127 regarding
the need for childhood vaccination products that result in fewer or no
significant adverse reactions; surveying Federal, State, and local
programs and activities related to gathering information on injuries
associated with the administration of childhood vaccines, including the
adverse reaction reporting requirements of section 2125(b); advising
the Secretary on the methods of obtaining, compiling, publishing, and
using credible data related to the frequency and severity of adverse
reactions associated with childhood vaccines; and recommending to the
Director of the National Vaccine Program that vaccine safety research
be conducted on various vaccine injuries.
The ACCV consists of nine voting members appointed by the Secretary
as follows: (1) Three health professionals, who are not employees of
the United States Government and have expertise in the health care of
children, and the epidemiology, etiology, and prevention of childhood
diseases, and the adverse reactions associated with vaccines, at least
two shall be pediatricians; (2) three members from the general public,
at least two shall be legal representatives (parents or guardians) of
children who have suffered a vaccine-related injury or death; and (3)
three attorneys, at least one shall be an attorney whose specialty
includes representation of persons who have suffered a vaccine-related
injury or death, and one shall be an attorney whose specialty includes
representation of vaccine manufacturers. In addition, the Director of
the National Institutes of Health, the Assistant Secretary for Health,
the Director of the Centers for Disease Control and Prevention, and the
Commissioner of the Food and Drug Administration (or the designees of
such officials) serve as nonvoting ex officio members.
Specifically, HRSA is requesting nominations for three voting
members of the ACCV representing: (1) A pediatrician who has expertise
in the health care of children, the epidemiology, etiology, and
prevention of childhood diseases, and the adverse reactions associated
with vaccines; (2) a member of the general public who is the legal
representative of a child who has suffered a vaccine injury or death;
and (3) an attorney whose specialty includes representation of persons
who have suffered vaccine injuries or deaths. Nominees will be invited
to serve a 3-year term beginning January 1, 2008, and ending December
31, 2010.
Interested persons may nominate one or more qualified persons for
membership on the ACCV. Nominations shall state that the nominee is
willing to serve as a member of the ACCV and appears to have no
conflict of interest that would preclude the ACCV membership. Potential
candidates will be asked to provide detailed information concerning
consultancies, research grants, or contracts to permit evaluation of
possible sources of conflicts of interest. A curriculum vitae or resume
should be submitted with the nomination.
The Department of Health and Human Services has special interest in
assuring that women, minority groups, and the physically disabled are
adequately represented on advisory committees; and therefore, extends
particular encouragement to nominations for appropriately qualified
female, minority, or disabled candidates.
Dated: June 11, 2007.
Caroline Lewis,
Associate Administrator for Management.
[FR Doc. E7-11548 Filed 6-14-07; 8:45 am]
BILLING CODE 4165-15-P
